Latest European Markets News

Askari Metals is gearing up for a pivotal shareholder meeting to approve its Ethiopian gold and copper acquisition, while restructuring debt and expanding European investor outreach.

Medical Developments International Ltd reported an 18% increase in revenue to $39.1 million for FY25, returning to profitability with a net profit after tax of $0.1 million. The company advanced its Penthrox market expansion through regulatory approvals and new partnerships.

Medical Developments International reports a strong FY25 with significant margin gains and strategic progress, setting the stage for accelerated Penthrox expansion in FY26.

Telix Pharmaceuticals reported a robust 63% increase in revenue to $390.4 million for the first half of 2025, driven by strong Illuccix sales and the acquisition of RLS Radiopharmacies. Despite this growth, the company recorded a net loss of $2.3 million, reflecting increased investments and finance costs.

Energy One Limited (ASX – EOL) delivered a robust FY25 performance, posting 17% revenue growth to $61.4 million alongside a 74% surge in net profit, underpinned by strong market expansion and strategic investments in cybersecurity and product innovation.

Sarytogan Graphite Limited secures a strategic A$3.6 million investment from Kazakh high-net-worth investor Dias Sarsenov, accelerating its Definitive Feasibility Study for a critical graphite project vital to Europe’s raw materials supply.

Orbital Corporation has denied any undisclosed information behind its recent share price jump, attributing market interest to strategic leadership appointments aimed at expanding its UAV propulsion business.

Neuren Pharmaceuticals reports a 16% rise in Q2 2025 royalties driven by Acadia’s DAYBUE sales growth and expanding patient base in the US. Full-year sales guidance remains strong with European market entry on the horizon.

AML3D has appointed German firm DMFG Solutions as a second European distributor, complementing its recent UK partnership and supporting a AU$5 million investment in a new technology centre.

Surefire Resources NL has progressed drilling at its Yidby Gold Project with promising metallurgical results, while advancing development of its Victory Bore critical minerals deposit. The company also launched a capital raising to support ongoing exploration and development.

Argent BioPharma has achieved a significant milestone by commencing formal supply of its EU-GMP cannabinoid API for epilepsy treatment at a leading Slovenian hospital and gaining prescription approval for CannEpil™ in Germany, marking key steps in its European expansion.

South Harz Potash has completed a partial entitlement offer raising A$566,000, with directors backing the raise, as it pushes to secure the full A$3.11 million to fund its dual-asset growth strategy in Germany.